Vascular endothelial growth factor (VEGF), which can be seen as the most prominent proangiogenic molecule, has been shown to be an independent prognostic parameter in patients with all stages of ovarian cancer [3]. The gene discussed is VEGFA; the disease is ovarian carcinoma.